APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Antibiotic Treatment Medication

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Antibiotic Treatment Medication Market Outlook and Growth Opportunities 2026

22 December 2025209 pages

Choose your research edition.

Industry ResearchVeterinary Antibiotic Treatment Medication Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Antibiotic Treatment Medication Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Veterinary Antibiotic Treatment Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Antibiotic Treatment Medication Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Antibiotic Treatment Medication Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Veterinary Antibiotic Treatment Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Antibiotic Treatment Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Antibiotic Treatment Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Antibiotic Treatment Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Antibiotic Treatment Medication market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Antibiotic Treatment Medication market include Boehringer Ingelheim GmbH, Ceva Santé Animale, Cymedica, Dechra, Elanco, HealthforAnimals, Jinhe Biotechnology, Merial and Orion Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Veterinary Antibiotic Treatment Medication market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Antibiotic Treatment Medication and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Antibiotic Treatment Medication revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Veterinary Antibiotic Treatment Medication market.

Veterinary Antibiotic Treatment Medication Segment by Company

Boehringer Ingelheim GmbH

Ceva Santé Animale

Cymedica

Dechra

Elanco

HealthforAnimals

Jinhe Biotechnology

Merial

Orion Corporation

Phibro Animal Health Corporation

Vetoquinol

Virbac

Virbac Group

Zydus

Bayer HealthCare

Merck Animal Health

Zoetis

Veterinary Antibiotic Treatment Medication Segment by Type

Oral

Injection

Others

Veterinary Antibiotic Treatment Medication Segment by Application

Dogs

Cats

Others

Veterinary Antibiotic Treatment Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Antibiotic Treatment Medication status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Veterinary Antibiotic Treatment Medication key companies, revenue, market share, and recent developments.

3. To split the Veterinary Antibiotic Treatment Medication breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Veterinary Antibiotic Treatment Medication market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Antibiotic Treatment Medication significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Antibiotic Treatment Medication competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Antibiotic Treatment Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Antibiotic Treatment Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Antibiotic Treatment Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Antibiotic Treatment Medication industry.

Chapter 3: Detailed analysis of Veterinary Antibiotic Treatment Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Veterinary Antibiotic Treatment Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Veterinary Antibiotic Treatment Medication in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Antibiotic Treatment Medication Industry Trends Table 2. Veterinary Antibiotic Treatment Medication Industry Drivers Table 3. Veterinary Antibiotic Treatment Medication Industry Opportunities and Challenges Table 4. Veterinary Antibiotic Treatment Medication Industry Restraints Table 5. Global Veterinary Antibiotic Treatment Medication Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Antibiotic Treatment Medication Revenue Share by Company (2021-2026) Table 7. Global Veterinary Antibiotic Treatment Medication Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Veterinary Antibiotic Treatment Medication Key Company Manufacturing Base & Headquarters Table 9. Global Veterinary Antibiotic Treatment Medication Company, Product Type & Application Table 10. Global Veterinary Antibiotic Treatment Medication Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Veterinary Antibiotic Treatment Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oral Table 15. Significant Companies of Injection Table 16. Significant Companies of Others Table 17. Global Veterinary Antibiotic Treatment Medication Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Veterinary Antibiotic Treatment Medication Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Veterinary Antibiotic Treatment Medication Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Veterinary Antibiotic Treatment Medication Sales Value Share by Type (2021-2026) Table 21. Global Veterinary Antibiotic Treatment Medication Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Dogs Table 23. Significant Companies of Cats Table 24. Significant Companies of Others Table 25. Global Veterinary Antibiotic Treatment Medication Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Veterinary Antibiotic Treatment Medication Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Veterinary Antibiotic Treatment Medication Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Veterinary Antibiotic Treatment Medication Sales Value Share by Application (2021-2026) Table 29. Global Veterinary Antibiotic Treatment Medication Sales Value Share by Application (2027-2032) Table 30. Global Veterinary Antibiotic Treatment Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Veterinary Antibiotic Treatment Medication Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Veterinary Antibiotic Treatment Medication Sales Value Share by Region (2021-2026) Table 33. Global Veterinary Antibiotic Treatment Medication Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Veterinary Antibiotic Treatment Medication Sales Value Share by Region (2027-2032) Table 35. Global Veterinary Antibiotic Treatment Medication Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Veterinary Antibiotic Treatment Medication Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Veterinary Antibiotic Treatment Medication Sales Value Market Share by Country (2021-2026) Table 38. Global Veterinary Antibiotic Treatment Medication Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Veterinary Antibiotic Treatment Medication Sales Value Market Share by Country (2027-2032) Table 40. Boehringer Ingelheim GmbH Company Information Table 41. Boehringer Ingelheim GmbH Business Overview Table 42. Boehringer Ingelheim GmbH Veterinary Antibiotic Treatment Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Boehringer Ingelheim GmbH Veterinary Antibiotic Treatment Medication Product Portfolio Table 44. Boehringer Ingelheim GmbH Recent Development Table 45. Ceva Santé Animale Company Information Table 46. Ceva Santé Animale Business Overview Table 47. Ceva Santé Animale Veterinary Antibiotic Treatment Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Ceva Santé Animale Veterinary Antibiotic Treatment Medication Product Portfolio Table 49. Ceva Santé Animale Recent Development Table 50. Cymedica Company Information Table 51. Cymedica Business Overview Table 52. Cymedica Veterinary Antibiotic Treatment Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Cymedica Veterinary Antibiotic Treatment Medication Product Portfolio Table 54. Cymedica Recent Development Table 55. Dechra Company Information Table 56. Dechra Business Overview Table 57. Dechra Veterinary Antibiotic Treatment Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Dechra Veterinary Antibiotic Treatment Medication Product Portfolio Table 59. Dechra Recent Development Table 60. Elanco Company Information Table 61. Elanco Business Overview Table 62. Elanco Veterinary Antibiotic Treatment Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Elanco Veterinary Antibiotic Treatment Medication Product Portfolio Table 64. Elanco Recent Development Table 65. HealthforAnimals Company Information Table 66. HealthforAnimals Business Overview Table 67. HealthforAnimals Veterinary Antibiotic Treatment Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. HealthforAnimals Veterinary Antibiotic Treatment Medication Product Portfolio Table 69. HealthforAnimals Recent Development Table 70. Jinhe Biotechnology Company Information Table 71. Jinhe Biotechnology Business Overview Table 72. Jinhe Biotechnology Veterinary Antibiotic Treatment Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Jinhe Biotechnology Veterinary Antibiotic Treatment Medication Product Portfolio Table 74. Jinhe Biotechnology Recent Development Table 75. Merial Company Information Table 76. Merial Business Overview Table 77. Merial Veterinary Antibiotic Treatment Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Merial Veterinary Antibiotic Treatment Medication Product Portfolio Table 79. Merial Recent Development Table 80. Orion Corporation Company Information Table 81. Orion Corporation Business Overview Table 82. Orion Corporation Veterinary Antibiotic Treatment Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Orion Corporation Veterinary Antibiotic Treatment Medication Product Portfolio Table 84. Orion Corporation Recent Development Table 85. Phibro Animal Health Corporation Company Information Table 86. Phibro Animal Health Corporation Business Overview Table 87. Phibro Animal Health Corporation Veterinary Antibiotic Treatment Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Phibro Animal Health Corporation Veterinary Antibiotic Treatment Medication Product Portfolio Table 89. Phibro Animal Health Corporation Recent Development Table 90. Vetoquinol Company Information Table 91. Vetoquinol Business Overview Table 92. Vetoquinol Veterinary Antibiotic Treatment Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Vetoquinol Veterinary Antibiotic Treatment Medication Product Portfolio Table 94. Vetoquinol Recent Development Table 95. Virbac Company Information Table 96. Virbac Business Overview Table 97. Virbac Veterinary Antibiotic Treatment Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Virbac Veterinary Antibiotic Treatment Medication Product Portfolio Table 99. Virbac Recent Development Table 100. Virbac Group Company Information Table 101. Virbac Group Business Overview Table 102. Virbac Group Veterinary Antibiotic Treatment Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Virbac Group Veterinary Antibiotic Treatment Medication Product Portfolio Table 104. Virbac Group Recent Development Table 105. Zydus Company Information Table 106. Zydus Business Overview Table 107. Zydus Veterinary Antibiotic Treatment Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Zydus Veterinary Antibiotic Treatment Medication Product Portfolio Table 109. Zydus Recent Development Table 110. Bayer HealthCare Company Information Table 111. Bayer HealthCare Business Overview Table 112. Bayer HealthCare Veterinary Antibiotic Treatment Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Bayer HealthCare Veterinary Antibiotic Treatment Medication Product Portfolio Table 114. Bayer HealthCare Recent Development Table 115. Merck Animal Health Company Information Table 116. Merck Animal Health Business Overview Table 117. Merck Animal Health Veterinary Antibiotic Treatment Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Merck Animal Health Veterinary Antibiotic Treatment Medication Product Portfolio Table 119. Merck Animal Health Recent Development Table 120. Zoetis Company Information Table 121. Zoetis Business Overview Table 122. Zoetis Veterinary Antibiotic Treatment Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Zoetis Veterinary Antibiotic Treatment Medication Product Portfolio Table 124. Zoetis Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Veterinary Antibiotic Treatment Medication Product Image Figure 2. Global Veterinary Antibiotic Treatment Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Antibiotic Treatment Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Antibiotic Treatment Medication Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oral Image Figure 8. Injection Image Figure 9. Others Image Figure 10. Global Veterinary Antibiotic Treatment Medication Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Veterinary Antibiotic Treatment Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Veterinary Antibiotic Treatment Medication Sales Value Share by Type (2021-2032) Figure 13. Dogs Image Figure 14. Cats Image Figure 15. Others Image Figure 16. Global Veterinary Antibiotic Treatment Medication Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Veterinary Antibiotic Treatment Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Veterinary Antibiotic Treatment Medication Sales Value Share by Application (2021-2032) Figure 19. Global Veterinary Antibiotic Treatment Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Veterinary Antibiotic Treatment Medication Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Veterinary Antibiotic Treatment Medication Sales Value (2021-2032) & (US$ Million) Figure 22. North America Veterinary Antibiotic Treatment Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Veterinary Antibiotic Treatment Medication Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Veterinary Antibiotic Treatment Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Veterinary Antibiotic Treatment Medication Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Veterinary Antibiotic Treatment Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Veterinary Antibiotic Treatment Medication Sales Value (2021-2032) & (US$ Million) Figure 28. South America Veterinary Antibiotic Treatment Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Veterinary Antibiotic Treatment Medication Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Veterinary Antibiotic Treatment Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
  • Others
Applications
  • Dogs
  • Cats
  • Others
Companies covered
  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Cymedica
  • Dechra
  • Elanco
  • HealthforAnimals
  • Jinhe Biotechnology
  • Merial
  • Orion Corporation
  • Phibro Animal Health Corporation
  • Vetoquinol
  • Virbac
  • Virbac Group
  • Zydus
  • Bayer HealthCare
  • Merck Animal Health
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Antibiotic Treatment Medication Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Antibiotic Treatment Medication Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Veterinary Antibiotic Treatment Medication Market Dynamics
  1. 2.1 Veterinary Antibiotic Treatment Medication Industry Trends
  2. 2.2 Veterinary Antibiotic Treatment Medication Industry Drivers
  3. 2.3 Veterinary Antibiotic Treatment Medication Industry Opportunities and Challenges
  4. 2.4 Veterinary Antibiotic Treatment Medication Industry Restraints
3 Veterinary Antibiotic Treatment Medication Market by Company
  1. 3.1 Global Veterinary Antibiotic Treatment Medication Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Antibiotic Treatment Medication Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Antibiotic Treatment Medication Company Ranking (2024-2026)
  4. 3.4 Global Veterinary Antibiotic Treatment Medication Company Manufacturing Base and Headquarters
  5. 3.5 Global Veterinary Antibiotic Treatment Medication Company Product Type and Application
  6. 3.6 Global Veterinary Antibiotic Treatment Medication Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Veterinary Antibiotic Treatment Medication Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Veterinary Antibiotic Treatment Medication Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Veterinary Antibiotic Treatment Medication Market by Type
  1. 4.1 Veterinary Antibiotic Treatment Medication Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.1.3 Others
  5. 4.2 Global Veterinary Antibiotic Treatment Medication Sales Value by Type
  6. 4.2.1 Global Veterinary Antibiotic Treatment Medication Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Veterinary Antibiotic Treatment Medication Sales Value by Type (2021-2032)
  8. 4.2.3 Global Veterinary Antibiotic Treatment Medication Sales Value Share by Type (2021-2032)
5 Veterinary Antibiotic Treatment Medication Market by Application
  1. 5.1 Veterinary Antibiotic Treatment Medication Application Introduction
  2. 5.1.1 Dogs
  3. 5.1.2 Cats
  4. 5.1.3 Others
  5. 5.2 Global Veterinary Antibiotic Treatment Medication Sales Value by Application
  6. 5.2.1 Global Veterinary Antibiotic Treatment Medication Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Antibiotic Treatment Medication Sales Value by Application (2021-2032)
  8. 5.2.3 Global Veterinary Antibiotic Treatment Medication Sales Value Share by Application (2021-2032)
6 Veterinary Antibiotic Treatment Medication Regional Value Analysis
  1. 6.1 Global Veterinary Antibiotic Treatment Medication Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Antibiotic Treatment Medication Sales Value by Region (2021-2032)
  3. 6.2.1 Global Veterinary Antibiotic Treatment Medication Sales Value by Region: 2021-2026
  4. 6.2.2 Global Veterinary Antibiotic Treatment Medication Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Antibiotic Treatment Medication Sales Value (2021-2032)
  7. 6.3.2 North America Veterinary Antibiotic Treatment Medication Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Veterinary Antibiotic Treatment Medication Sales Value (2021-2032)
  10. 6.4.2 Europe Veterinary Antibiotic Treatment Medication Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Veterinary Antibiotic Treatment Medication Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Veterinary Antibiotic Treatment Medication Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Veterinary Antibiotic Treatment Medication Sales Value (2021-2032)
  16. 6.6.2 South America Veterinary Antibiotic Treatment Medication Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Veterinary Antibiotic Treatment Medication Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Veterinary Antibiotic Treatment Medication Sales Value Share by Country, 2025 VS 2032
7 Veterinary Antibiotic Treatment Medication Country-level Value Analysis
  1. 7.1 Global Veterinary Antibiotic Treatment Medication Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Antibiotic Treatment Medication Sales Value by Country (2021-2032)
  3. 7.2.1 Global Veterinary Antibiotic Treatment Medication Sales Value by Country (2021-2026)
  4. 7.2.2 Global Veterinary Antibiotic Treatment Medication Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Veterinary Antibiotic Treatment Medication Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Veterinary Antibiotic Treatment Medication Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Veterinary Antibiotic Treatment Medication Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim GmbH
  2. 8.1.1 Boehringer Ingelheim GmbH Company Information
  3. 8.1.2 Boehringer Ingelheim GmbH Business Overview
  4. 8.1.3 Boehringer Ingelheim GmbH Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim GmbH Veterinary Antibiotic Treatment Medication Product Portfolio
  6. 8.1.5 Boehringer Ingelheim GmbH Recent Developments
  7. 8.2 Ceva Santé Animale
  8. 8.2.1 Ceva Santé Animale Company Information
  9. 8.2.2 Ceva Santé Animale Business Overview
  10. 8.2.3 Ceva Santé Animale Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Santé Animale Veterinary Antibiotic Treatment Medication Product Portfolio
  12. 8.2.5 Ceva Santé Animale Recent Developments
  13. 8.3 Cymedica
  14. 8.3.1 Cymedica Company Information
  15. 8.3.2 Cymedica Business Overview
  16. 8.3.3 Cymedica Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cymedica Veterinary Antibiotic Treatment Medication Product Portfolio
  18. 8.3.5 Cymedica Recent Developments
  19. 8.4 Dechra
  20. 8.4.1 Dechra Company Information
  21. 8.4.2 Dechra Business Overview
  22. 8.4.3 Dechra Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dechra Veterinary Antibiotic Treatment Medication Product Portfolio
  24. 8.4.5 Dechra Recent Developments
  25. 8.5 Elanco
  26. 8.5.1 Elanco Company Information
  27. 8.5.2 Elanco Business Overview
  28. 8.5.3 Elanco Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Elanco Veterinary Antibiotic Treatment Medication Product Portfolio
  30. 8.5.5 Elanco Recent Developments
  31. 8.6 HealthforAnimals
  32. 8.6.1 HealthforAnimals Company Information
  33. 8.6.2 HealthforAnimals Business Overview
  34. 8.6.3 HealthforAnimals Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HealthforAnimals Veterinary Antibiotic Treatment Medication Product Portfolio
  36. 8.6.5 HealthforAnimals Recent Developments
  37. 8.7 Jinhe Biotechnology
  38. 8.7.1 Jinhe Biotechnology Company Information
  39. 8.7.2 Jinhe Biotechnology Business Overview
  40. 8.7.3 Jinhe Biotechnology Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jinhe Biotechnology Veterinary Antibiotic Treatment Medication Product Portfolio
  42. 8.7.5 Jinhe Biotechnology Recent Developments
  43. 8.8 Merial
  44. 8.8.1 Merial Company Information
  45. 8.8.2 Merial Business Overview
  46. 8.8.3 Merial Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merial Veterinary Antibiotic Treatment Medication Product Portfolio
  48. 8.8.5 Merial Recent Developments
  49. 8.9 Orion Corporation
  50. 8.9.1 Orion Corporation Company Information
  51. 8.9.2 Orion Corporation Business Overview
  52. 8.9.3 Orion Corporation Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Orion Corporation Veterinary Antibiotic Treatment Medication Product Portfolio
  54. 8.9.5 Orion Corporation Recent Developments
  55. 8.10 Phibro Animal Health Corporation
  56. 8.10.1 Phibro Animal Health Corporation Company Information
  57. 8.10.2 Phibro Animal Health Corporation Business Overview
  58. 8.10.3 Phibro Animal Health Corporation Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Phibro Animal Health Corporation Veterinary Antibiotic Treatment Medication Product Portfolio
  60. 8.10.5 Phibro Animal Health Corporation Recent Developments
  61. 8.11 Vetoquinol
  62. 8.11.1 Vetoquinol Company Information
  63. 8.11.2 Vetoquinol Business Overview
  64. 8.11.3 Vetoquinol Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Vetoquinol Veterinary Antibiotic Treatment Medication Product Portfolio
  66. 8.11.5 Vetoquinol Recent Developments
  67. 8.12 Virbac
  68. 8.12.1 Virbac Company Information
  69. 8.12.2 Virbac Business Overview
  70. 8.12.3 Virbac Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Virbac Veterinary Antibiotic Treatment Medication Product Portfolio
  72. 8.12.5 Virbac Recent Developments
  73. 8.13 Virbac Group
  74. 8.13.1 Virbac Group Company Information
  75. 8.13.2 Virbac Group Business Overview
  76. 8.13.3 Virbac Group Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Virbac Group Veterinary Antibiotic Treatment Medication Product Portfolio
  78. 8.13.5 Virbac Group Recent Developments
  79. 8.14 Zydus
  80. 8.14.1 Zydus Company Information
  81. 8.14.2 Zydus Business Overview
  82. 8.14.3 Zydus Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Zydus Veterinary Antibiotic Treatment Medication Product Portfolio
  84. 8.14.5 Zydus Recent Developments
  85. 8.15 Bayer HealthCare
  86. 8.15.1 Bayer HealthCare Company Information
  87. 8.15.2 Bayer HealthCare Business Overview
  88. 8.15.3 Bayer HealthCare Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bayer HealthCare Veterinary Antibiotic Treatment Medication Product Portfolio
  90. 8.15.5 Bayer HealthCare Recent Developments
  91. 8.16 Merck Animal Health
  92. 8.16.1 Merck Animal Health Company Information
  93. 8.16.2 Merck Animal Health Business Overview
  94. 8.16.3 Merck Animal Health Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Merck Animal Health Veterinary Antibiotic Treatment Medication Product Portfolio
  96. 8.16.5 Merck Animal Health Recent Developments
  97. 8.17 Zoetis
  98. 8.17.1 Zoetis Company Information
  99. 8.17.2 Zoetis Business Overview
  100. 8.17.3 Zoetis Veterinary Antibiotic Treatment Medication Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Zoetis Veterinary Antibiotic Treatment Medication Product Portfolio
  102. 8.17.5 Zoetis Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst